Comparison of survival between primary debulking surgery and neoadjuvant chemotherapy for stage III/IV ovarian, tubal and peritoneal cancers in phase III randomised trial-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Comparison of survival between primary debulking surgery and neoadjuvant chemotherapy for stage III/IV ovarian, tubal and peritoneal cancers in phase III randomised trial

Published:2020-05 Issue: Volume:130 Page:114-125
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Onda Takashi,Satoh Toyomi,Ogawa Gakuto,Saito Toshiaki,Kasamatsu Takahiro,Nakanishi Toru,Mizutani Tomonori,Takehara Kazuhiro,Okamoto Aikou,Ushijima Kimio,Kobayashi Hiroaki,Kawana Kei,Yokota Harushige,Takano Masashi,Kanao Hiroyuki^ORCID,Watanabe Yoh,Yamamoto Kaichiro,Yaegashi Nobuo,Kamura Toshiharu,Yoshikawa Hiroyuki

Funder

Chugai

Kaken

Taiho

Daiichi-Sankyo

Mochida

Meiji Yasuda Health Development Foundation

AstraZeneca

Nippon Kayaku

Kyowa Kirin

Eisai

Tsumura

Beyer

Aska

Meiji

Fuji

Novartis

Pfizer

Kissei

Shionogi

GenoDive

CMIC

Shinnihonseiyaku

MSD

Takeda

Abbvie

Ono

Yakult

Bayer

Zeria

BrightPath Biotherapeutics

GSK

Health Sciences Research

Cancer Research

Ministry of Health, Labour and Welfare, Japan

National Cancer Center Research and Development Funds

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference30 articles.

1. Carcinoma of the ovary. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer;Heintz;Int J Gynaecol Obstet,2006

2. Cytoreductive surgery for advanced stages of ovarian cancer;Dauplat;Semin Surg Oncol,2000

3. Neoadjuvant chemotherapy and interval debulking for advanced epithelial ovarian cancer;Jacob;Gynecol Oncol,1991

4. Neoadjuvant chemotherapy or primary surgery in advanced epithelial ovarian carcinoma;Kayikçioḡlu;Int J Gynecol Cancer,2001

5. Neoadjuvant chemotherapy for advanced epithelial ovarian carcinoma: a retrospective case-control study;Vrščaj;Eur J Gynaecol Oncol,2002

Cited by 126 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multitask prediction models for serous ovarian cancer by preoperative CT image assessments based on radiomics;Frontiers in Medicine;2024-02-06

2. Efficacy and safety of neoadjuvant chemotherapy containing anti-angiogenic drugs, immunotherapy, or PARP inhibitors for ovarian cancer;Critical Reviews in Oncology/Hematology;2024-02

3. ESGO–ESMO–ESP consensus conference recommendations on ovarian cancer: pathology and molecular biology and early, advanced and recurrent disease;Annals of Oncology;2024-02

4. An increase of serum CA-125 to two times of nadir level strongly predicts the image-identified recurrence of serous ovarian cancer;2024-01-10

5. Relapsed Ovarian Cancer Patients with Ascites and/or Pleural Effusion Still Benefit from Treatment: A Real-Life Study;Cancers;2023-12-28

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3